Elsevier

Gynecologic Oncology

Volume 84, Issue 3, March 2002, Pages 363-367
Gynecologic Oncology

Regular Article
Use of Complementary and Alternative Medicine among Women with Gynecologic Cancers

https://doi.org/10.1006/gyno.2001.6515Get rights and content

Abstract

Objective. The aim of this study was to determine the prevalence and types of complementary and alternative medicine (CAM) usage by women with gynecologic cancer in an outpatient midwestern university practice.

Methods. Any patient with a gynecologic cancer seen in the outpatient clinic of the gynecologic oncology division at Washington University over a 3-month period was eligible, excluding those patients with a new cancer diagnosis. Subjects completed a questionnaire anonymously. Two by two comparisons were made using the Fisher exact test and P was considered significant at P < 0.05.

Results. Nearly half (49.6%) of 113 respondents had used CAM since being diagnosed with cancer. Characteristics significantly associated with CAM use include annual income greater than $30,000, cancer site of origin other than the cervix, and use of CAM prior to cancer diagnosis. Users with annual incomes greater than $30,000 were significantly more likely to use CAM in the “other” category that included acupuncture, reflexology, and electromagnetic therapy. Fewer than 25% of CAM users received information regarding CAM from a physician, nurse, or practitioner of CAM. Women used CAM in hopes of achieving a wide range of potential benefits including both improved well-being and anti-cancer effects. The most common actual benefit these women perceived was an improvement in psychosocial well-being, including increased hope or optimism.

Conclusions. American patients with gynecologic cancer frequently use CAM in addition to standard medical therapy. Oncologists caring for women with gynecologic cancer should initiate a dialogue about usage of CAM, discussing the potential adverse effects of CAM and the patient's therapeutic goals.

References (23)

  • M Grouhi et al.

    Pseudoallergic toxic reaction

    Ann Allergy Asthma Immunol

    (2000)
  • DM Eisenberg et al.

    Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey

    JAMA

    (1998)
  • SD Begbie et al.

    Patterns of alternative medicine use by cancer patients

    Med J Aust

    (1996)
  • SM Downer et al.

    Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment

    BMJ

    (1994)
  • T Risberg et al.

    Use of non-proven therapies

    Differences in attitudes between Norwegian patients with non-malignant disease and patients suffering from cancer. Acta Oncol

    (1995)
  • E Ernst et al.

    The prevalence of complementary/alternative medicine in cancer: a systematic review

    Cancer

    (1998)
  • M Liu et al.

    Cross-sectional study of use of alternative medicines in Chinese cancer patients

    Jpn J Clin Oncol

    (1997)
  • BR Cassileth

    Complementary therapies: overview and state of the art

    Cancer Nurs

    (1999)
  • KM Yates et al.

    “Herbal ecstasy”: a case series of adverse reactions

    N Z Med J

    (2000)
  • SL Soon et al.

    Recurrent erythema nodosum associated with Echinacea herbal therapy

    J Am Acad Dermatol

    (2001)
  • M Shannon

    Alternative medicines toxicology: a review of selected agents

    J Toxicol Clin Toxicol

    (1999)
  • Cited by (102)

    • Use of complementary and alternative medicine in cancer: A Tunisian single-center experience

      2020, Bulletin du Cancer
      Citation Excerpt :

      Patients wish to enhance the body's ability to fight cancer and to improve physical and emotional well-being through CAM. In addition, dissatisfaction with some aspects of conventional health care, poor doctor–patient relationship and desperation push patients frequently to consider CAM use [5,6]. A meta-analysis found an increase in CAM use, as about 40% of cancer patients reported current or previous use of such therapies [7].

    • Integrative Oncology and Ethics

      2017, Ethical Challenges in Oncology: Patient Care, Research, Education, and Economics
    View all citing articles on Scopus
    1

    To whom reprint requests should be addressed at Department of Obstetrics and Gynecology, University of Washington, 1959 NE Pacific, Box 356460, Seattle, WA 98195. Fax: (206) 543-3915. E-mail: [email protected].

    View full text